Rich JD - Search Results

1

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.

Curtis M, Berk J, Larney S, Rich JD, Stoové M. Curtis M, et al. Among authors: rich jd. Int J Drug Policy. 2022 Feb;100:103572. doi: 10.1016/j.drugpo.2021.103572. Epub 2022 Jan 5. Int J Drug Policy. 2022. PMID: 34998045 Free PMC article. No abstract available.

2

Methadone for prisoners--Authors' reply.

Rich JD, McKenzie M, Larney S, Noska A, Clark J. Rich JD, et al. Lancet. 2016 Jan 16;387(10015):225. doi: 10.1016/S0140-6736(16)00046-5. Epub 2016 Jan 15. Lancet. 2016. PMID: 26842295 No abstract available.

3

What are the greatest health challenges facing people who are incarcerated? We need to ask them.

Berk J, Rich JD, Brinkley-Rubinstein L. Berk J, et al. Among authors: rich jd. Lancet Public Health. 2021 Oct;6(10):e703-e704. doi: 10.1016/S2468-2667(21)00074-8. Epub 2021 Jun 9. Lancet Public Health. 2021. PMID: 34115973 Free PMC article. No abstract available.

4

Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting.

Berk J, Del Pozo B, Rich JD, Lee JD. Berk J, et al. Among authors: rich jd. J Addict Med. 2022 Jul-Aug 01;16(4):396-398. doi: 10.1097/ADM.0000000000000942. Epub 2021 Dec 23. J Addict Med. 2022. PMID: 34954747 Free PMC article.

5

"It's probably going to save my life;" attitudes towards treatment among people incarcerated in the era of fentanyl.

Kaplowitz E, Macmadu A, Green TC, Berk J, Rich JD, Brinkley-Rubinstein L. Kaplowitz E, et al. Among authors: rich jd. Drug Alcohol Depend. 2022 Mar 1;232:109325. doi: 10.1016/j.drugalcdep.2022.109325. Epub 2022 Jan 22. Drug Alcohol Depend. 2022. PMID: 35114617 Free PMC article.

6

Use of long-acting injectable buprenorphine in the correctional setting.

Martin RA, Berk J, Rich JD, Kang A, Fritsche J, Clarke JG. Martin RA, et al. Among authors: rich jd. J Subst Abuse Treat. 2022 Nov;142:108851. doi: 10.1016/j.jsat.2022.108851. Epub 2022 Jul 29. J Subst Abuse Treat. 2022. PMID: 35939914 Free PMC article.

7

A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.

Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. Brinkley-Rubinstein L, et al. Drug Alcohol Depend. 2018 Mar 1;184:57-63. doi: 10.1016/j.drugalcdep.2017.11.023. Epub 2018 Jan 31. Drug Alcohol Depend. 2018. PMID: 29402680 Free PMC article. Clinical Trial.

8

MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.

Berk J, Brinkley-Rubinstein L, Murphy M, Chan P, Rich J. Berk J, et al. Lancet. 2021 Mar 6;397(10277):877-878. doi: 10.1016/S0140-6736(21)00354-8. Epub 2021 Feb 19. Lancet. 2021. PMID: 33617772 Free PMC article. No abstract available.

9

Treatment preference for opioid use disorder among people who are incarcerated.

Kaplowitz E, Truong AQ, Berk J, Martin RA, Clarke JG, Wieck M, Rich J, Brinkley-Rubinstein L. Kaplowitz E, et al. J Subst Abuse Treat. 2022 Jun;137:108690. doi: 10.1016/j.jsat.2021.108690. Epub 2021 Dec 13. J Subst Abuse Treat. 2022. PMID: 34930575 Free PMC article.

10

Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N. Rich JD, et al. Lancet. 2015 Jul 25;386(9991):350-9. doi: 10.1016/S0140-6736(14)62338-2. Epub 2015 May 28. Lancet. 2015. PMID: 26028120 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters